Introduction. The study of growth factor expression allows further development of therapeutic modalities in the treatment of malignant diseases of the skin. This study aims to determine the relationship between the level of VEGF expression and morphological parameters (biological behavior of lesions, histological type, the defect on the surface, the density of infl ammatory infi ltrate, mitotic index, stage of growth and cell type) in melanocytic nevi and melanomas of the skin in different regions. Methods. The study included skin biopsy material of 73 patients, divided in two groups (group I-melanomas, group II-nevi). The following parameters were determined: histological type, thickness of alteration (Breslow), Clark level, pTNM stage, the width of alteration, the density of lymphocytic infi ltration of the tumor, mitotic index, stage of tumor growth, the presence of ulceration, tumor cell type, location and level of expression of VEGF. Results. Most of benign melanocytic alterations in the skin shows low expression levels of VEGF in 91.18% of cases. In the group of melanomas, a high level of expression was seen in 61.54 % of cases. Nodular and acral lentiginous type of melanoma more often showed a high level of expression of VEGF, while superfi cial spreading melanoma often showed a low level of VEGF expression. Conclusion. Benign melanocytic alterations have low, while malignant melanocytic alterations have high level of expression of VEGF.
Nevomelanocytic nevi are formed by nevomelanocytic clusters in the epidermis (junctional nevus), in the dermis (intradermal nevus), or on both places (compound nevus). 1 They are distinguished from other nevi by the ability of malignant alteration towards skin melanoma. 2 Melanoma is a heterogeneous disease of the skin and mucous membranes which shows a signifi cant increase in worldwide incidence in the past decades (from 2.7 to 6.0 of 100 000 residents per year in men and from 4.6 to 8.5 of 100 000 residents in women). 3 Because of clinical and biological characteristics, the World Health Organization (WHO) has offered the classifi cation of melanoma, where because of the frequency,are described as superficial spreading melanoma, nodular, and acral lentiginous melanoma. 4 The skin retains the ability of rapid neovascularization, or secondary angiogenesis in response to numerous pathological stimuli, injury, infl ammatory dermatoses, and neoplasia. 5 Processes that occur during the angiogenic cascade are regulated by various factors, stimulators and inhibitors, whose balance limits the process. 6 Stimulators of angiogenesis are: growth factor of endothelial cells lining the blood vessels (VEGF), basic and acidic fi broblast growth factors (b-FGF, aFGF, FGF-2, FGF-1), endothelial cell growth factor originating from platelets (PDECGF), angiopoetin-1, and others. 7 The VEGF family consists of fi ve isoforms: VEGF-A, VEGF-B, VEGF-C, VEGF-D, and placental growth factor. VEGF-A, also known as vascular permeability factor, or simply VEGF, was described as a potent endothelial cell mitogen which stimulates the proliferation and migration of endothelial cells. VEGF is overexpressed in almost all solid tumors and correlates with vascularity, grade, and prognosis. Several studies have examined the expression of members of the VEGF signaling pathway in melanoma. Secretion of VEGF occurs during progression of early cutaneous melanocytic lesions, with low VEGF expression in benign nevi increasing signifi cantly in dysplastic nevi and more so in malignant melanoma. 8 The transition of melanomas from the radial to the aggressive vertical growth phase is also marked by increased VEGF production. 9, 10 Tumor blood fl ow in melanomas thicker than 0.9 mm was detected using Doppler ultrasound, and endogenous VEGF expression and secretion in melanoma tumor cells were later established. 11 Statistical analysis showed that the expression rate of VEGF in choroidal melanoma was much higher than that in the control group, and was dependent on tumor size, which suggested that VEGF played a role in the progression of choroidal melanoma by stimulating angiogenesis required forpromotion of tumor growth. 12 The study of growth factor expression allows further development of therapeutic modalities in the treatment of malignant diseases of the skin. Targeted vascular treatment decreases the possibility of creating new blood vessels in tumor, and thus indirectly affects tumor cells and slows tumor growth and development. 13 The aim of this study was to determine the correlation between the level of VEGF expression and morphologic parameters (biologic behavior of lesion, histological type, surface defects, infl ammatory infi ltrate density, mitotic index, stage of growth, and cell type) in melanocytic nevi and skin melanoma fromdifferent anatomical regions.
Materials and methods

Patients
The research was done on bioptic skin samples of 73 patients with melanocytic skin alterations, taken at the Clinical Center, Banjaluka between 2004 to 2007. Based on histopathological analysis, patients were divided into two groups: group I -39 patients with melanoma and group II -34 patients with nevi.
Morphological analysis
In all specimens, the following was determined: the histological type-determined by the analysis of histological samples according to the WHO histological classifi cation; 4 the thickness of alteration; Clark level-determined histologically and by the layers of tumor location (level I to level V); pTNM stage-on the basis of histological analysis and insight into the history of the disease according to the 7th pTNM classifi cation; 14 tumor infi ltration by lymphocytes; mitotic index: the number of mitoses was determined in 10 visual fi elds at high magnifi cation; the estimation of growth phase: radial or vertical growth phase 4 ;the pres-ence of surface defect: presence or absence of ulceration; cell type of alteration: epitheloid cells, spindle cells, mixed type (epitheloid + spindle cells);localization: alterations have been classifi ed according to the localization into the following subgroups: head and neck, trunk, extremities.
Immunostaining
To detectthe primary antigen VEGF,commercial mouse monoclonal anti-human VEGF antibody (Daco M7273) was usedat a dilution of 1:25. For visualization, we used the LSAB + (Daco K0690) system and chromogen DAB Liquid (K3466).
The presence or absenceand the intensity of vascular endothelial growth factor was assessed by semi-quantitative ranking using a scale from 0 to 3, taking the level of immunostaining of keratinocytes as an internal control. The quantifi cation was as follows: score of 0, no difference in immunostaining for VEGF between melanocytes and ke- ratinocytes; score of 1 -less than 25% tumor cells show an expression of higher intensity compared to the level of staining of keratinocytes; score of 2 -25 -75% of tumor cells show an expression of higher intensity compared to the level of staining of keratinocytes ( Figure 1) ; score of 3 -more than 75% tumor cells show an expression of higher intensity compared to the level of staining of keratinocytes ( Figure 2 ).
Statistical analysis
The results were analyzed by methods of descriptive and correlative statistics. Statistical analysis was performed using the SPSS software version 15.0, and the following tests were applied: χ2 and the related methods of analysis of categorical variables (Fisher's exact test, Kendall tau rank correlation coeffi cient) and Mann Whitney U-test.
Results
The average age of examinees was 45 years. The gender distribution is 1,92:1 in favor of women.
Most of benign melanocytic alterations in the skin showed low expression level of VEGF (score of 0 and 1) in 91,18% of cases. In the group of melanomas, high expression levels were found in 61.54% of cases (level 2 and 3). A statistically signifi cant difference exists in the expression of VEGF in groups. In group I, expression was often high (score of 2 and 3), and in group II, more often the expression was low (score of 0 and 1) (χ2=21,658; df= 1; p<0.001) 1
Histological type. A statistically signifi cant difference was not found in level of VEGF expression when different histological types of nevi were compared (χ2=2.062; p=0.724). Nodular and acral lentiginous melanomas more often showed a high level of expression of VEGF, while superfi cial spreading melanomas often showed a low level of VEGF expression (χ2 = 6.858, p = 0.032) 1* .
The presence of surface defects. A statistically signifi cant difference was not present regarding the level of expression of VEGF and the presence of a defect in nevi (Fischer's test, p = 0.101). Unlike nevi, in the melanoma group there was a statistically signifi cant difference in the level of VEGF expression and the presence of ulceration was found (χ2= 4.545 p = 0.033) * .
The thickness of alteration. Based on statistical analysis, we can conclude that there was no statistically signifi cant correlation between the expression of VEGF and the thickness of nevi (χ2= 1.009, p = 0.604). A higher level of expression was present in melanomas that were thicker (higher stage according to Breslow) (χ2=11.211, p = 0.011, p<0,05).
Based on the analysis of the Mann-Whitney test, we can conclude that there was no statistically signifi cant differ-* Contact the corresponding author for the detailed data.
ence in the level of expression of VEGF and the width of benign melanocytic lesions (U = 38.000 for the signifi cance of 0.605) and in the melanoma group (U = 142.000 for the signifi cance of 0.273).
Tumor infi ltration by lymphocytes. Analysis showed no statistically signifi cant differences between nevi with different densities of lymphocytic infi ltration in relation to the expression of VEGF (Chi-square of 1.019, p = 0.601).
On the basis of statistical analysis, in the group of melanomas, we can conclude that there was a statistically significant difference in the level of expression of VEGF and the density of lymphocytic infi ltration (Chi-square of 8.555, p = 0.014, p<0,05). The low level of expression of VEGF is more common in melanomas with dense lymphocytic infi ltration, while a high level of expression was found in melanomas with rare lymphocytic infi ltrate * .
Mitotic index.
In the studied material, mitotic activity in benign melanocytic alterations was verifi ed in only one case (2.94%), and level of VEGF expression in this case was 1. In the group of melanomas, based on Kendall tau rank correlation coeffi cient, there was no statistically signifi cant difference in the level of VEGF expression in relation to mitotic activity (t= 0.256, p = 0.060) * .
Estimation of growth phase. Analysis revealed that there was no statistically signifi cant difference in the level of VEGF expression and the growth phase of nevi (Chisquare of 5, p = 0.07). Melanomas presented with vertical growth phase had showed a higher level of expression of VEGF (Chi-square of 4.840, p = 0.028, p<0.05) * .
Cell type of alteration. All examined nevi had an epitheloid cell type. Analysis of Chi square analysisshowed a statistically signifi cant difference in the level of VEGF expression and cell type of melanoma (Chi-square of 8.871 p = 0.031, p<0.05). A high level VEGF expression was more often verifi ed in melanomas with epitheloid cells * .
Localization. Analysis using Chi square test showed there was no statistically signifi cant difference in expression of VEGF, with respect to the localization of nevus (Chi-square of 2.765, p = 0.251). In the melanoma group based on Chi square test, we could conclude there was a statistically signifi cant difference in the level of expression of VEGF and localization of melanoma (Chi-square of 7.831, p = 0.05, p<0.05). Melanomas localized on the extremities showed a higher level of expression of VEGF (score 2 and 3), while melanomas localized on the head, neck and trunk showed a low level of expression of VEGF * .
Based on analysis of Kendall tau rank correlation coefficient, no signifi cant difference in the level of expression of VEGF and the level of invasion according to Clark was found (t= 0.244, p = 0.063) * .
Statistical analysis using Kendall tau rank correlation coeffi cient showed a statistically signifi cant difference in the level of VEGF expression and pT stage melanoma (t= 0.259, p = 0.050). Melanomas in higher pT stage of the disease showed higher expression of VEGF (score 2 and 3). 2**
Discussion
Early diagnosis and differentiation between benign and malignant tumors of the skin is of utmost importance. So far there is an insuffi cient number of studies that would indicate that routine screening for skin may be important in the prevention of malignant skin tumors and contribute to better treatment of patients suffering from these diseases. 15 In this study, we have found that melanocytic nevi showed expression of VEGF in the most cases (79.41%). The expression is usually at low grade (grade 1 immunostaining).
In the group of melanomas, a low expression of VEGF is present in 38.46% of the cases (score 0 and 1), while a high level of expression was present in 61.54% of the cases (score 2 and 3). Carazo and Peyri 16 reported that the majority of melanoma had showed lower levels of expression (score 0 and 1), which is different from our results. A logical explanation for thisis that the authors examined the selected group of melanomas ("thin melanomas" ie. Breslow less than 1 mm), while we presented results from anunselected group (Breslow thicknesseven greater than 1 mm). The results of Einspahr and associates suggest that the level of VEGF expression may be a signifi cant parameter which indicates the malignant transformation of melanocytic skin alterations. The study demonstrated that the level of VEGF expression in benign melanocytic alterations is low or absent, while in dysplastic nevi it is signifi cantly higher, and the expression is much higher in malignant melanocytic alterations (melanoma). Thus, increased expression of VEGF may be a good indicator of preneoplastic changes in melanocytic alterations. 17 Brychtova and collaborators determined the presence of VEGF expression in benign and malignant melanocytic alterations. More often, the high level of VEGF expression can statistically be verifi ed in melanomas in relation to nevi. 18 The difference in the level of VEGF expression and morphological parameters (histological type, the defect on the surface, the density of infl ammatory infi ltrate, mitotic index, stage of growth and cell type) has not been demonstrated in the examined nevi. In the melanoma group, a statistically signifi cant difference exists in the level of VEGF expression and the presence of ulceration and thick-** Individual morphological parameters and VEGF expression in the nevi and melanomas, with statistical analysis, may be obtained from the corresponding author.
ness according to Breslow. Boone and associates failed to demonstrate a positive correlation between the expression of VEGF-C and the presence of ulceration, tumor thickness according to Breslow, and the level of invasion according to Clark. 19 In our study, nodular and acral lentiginous types of melanoma were more likely to exhibit high VEGF expression level, while superfi cial spreading melanoma often showed a low level of expression of VEGF. These results are in line with literature data. 19 In the examined material, we did not fi nd malignant changes in Clark level I. A number of melanoma cases showed a high expression of VEGF (score 2 and 3) in 24 (61.54%) cases. The cases with higher expression are generally at higher Clark level. Based on analysis of Kendall's tau b test, we found no signifi cant difference in the level of expression of VEGF and the level of invasion according to Clark. Salven and associates also did not fi nd any differences in the manifestation of VEGF (measured by immunohistochemical methods) between small and large primary melanomas. 20 However, this contrary to other reports. Redondo and associates believe that the more Clark's or Breslow's level increases, the percentage of positive immunostaining for VEGF increases, thus linking it with the development of primary tumors, although a prognostic study has not been performed. 16, 21 Melanomas presented with vertical growth phase showed a higher level of VEGF expression. Looking at the value of immunostaining for VEGF according to the Breslow level, we found very important information which we consider fundamental: melanomas in radial growth phase, and those are the ones thathave not undergone change to malignant eclipse, show less VEGF, which is signifi cantly different as measured by precise Fisher's test (p = 0.002) compared to those melanomas who have already penetrated. 22 In our series, benign melanocytic lesions were located on the trunk in 26 (76.47%) cases, followed by the extremities in 5 (14.71%) casesand head and neck in 3 (8.82%) cases. Melanomas in our material were located on extremities in 15 (38.46%) cases, followed by head and neck in 13 (33.33%) cases and on the trunk in 11 (28.21%) cases. Melanomas located on the extremities showed a higher level of expression of VEGF (score 2 and 3), while melanomas located on the head, neck and trunk show a low level of expression of VEGF.
Melanocytic alterations show the expression of VEGF, regardless of their clinical behavior. Benign melanocytic alterations often indicate low, while malignant melanocytic alterations often show high level of expression of VEGF. Presence and level of expression of VEGF show no difference regarding to histological type, surface defect, density of infl ammatory infi ltrate, mitotic index, growth phase, cell type, and location of nevi. A high level expression of VEGF is present in the nodular and acral lentiginous types of melanoma, in melanomas with ulceration and rare infl ammatory infi ltrate in the stroma, high mitotic index, in higher stage disease (Breslow, Clark, pT), and in melanomas located on extremities.
